Design (Testphase)
Breakout & Setup
Tight Weekly Range (WCR≥90)
223
Hits
August 3, 2026
last calculated
Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q) · Market filter active: the list shows 100 hits from US
Weekly Closing Range ≥ 90 and Daily Closing Range ≥ 70 — a very tight, strong weekly range closing near the high.
Global filters: market cap of $50B or less (mega caps are cut from every scanner); 10- and 30-day ADR must be ≥ 1% (too little movement gets cut); names after a reverse split (distorted price history) and names with a red Stress RS (rating ≤ 30 — weak on stress days) are excluded.
🔔 Watch scanner
Terms in This Scanner Explained
(15)
- ADR (Average Daily Range)
- The average daily swing of a stock in percent - measured over 10 or 30 trading days (columns "ADR 10D/30D"). An ADR of 5% means: on a normal day the gap between the intraday low and high runs about 5%. Traders look for movement - that is why stocks with an ADR under 1% are filtered out globally. Not to be confused with ADR meaning "American Depositary Receipt" (a US certificate for foreign shares) - here ADR always means the daily swing.
- AI Classification
- Our company-by-company assessment of the AI boom based on SEC filings (the last four quarterly 10-Q reports and two annual 10-K reports): "Sells AI" (AI is a revenue source), "Threatened" (AI is a concrete business risk), "Uses AI" (operational use), or "Neutral" (no material AI exposure). Every classification requires at least two direct quote citations - otherwise the column shows "-". Not a quality judgment or a buy recommendation; the full file is on the stock page, methodology at /stocks/ai-rating-methodology.
- Analysis (Full Company Analysis)
- If the Analysis column shows "Read," there is an in-depth TickerGuard company analysis for this stock: business model, scanner findings, quarterly results, evidence from SEC filings, plus opportunities and risks. One click opens it directly.
- Avg/Yr 3Y (Average Annual Return)
- The stock's average annual return over the past 3 years. Shows at a glance whether a stock delivers over the long run or just had a short hot streak.
- Earnings Date
- The date of the next quarterly earnings report. Price gaps in either direction are common around this date - that is why we color it red when it is 7 days away or less, and yellow when it is 14 days away or less: elevated risk for fresh positions.
- EPS (Earnings per Share)
- Quarterly earnings divided by the number of shares outstanding. The most important growth metric: if EPS rises strongly over several quarters, the company is earning more money per share.
- Free Cash Flow (FCF)
- Operating cash flow minus capital expenditures - the money left over for everything else (debt paydown, acquisitions, or buybacks). Consistently positive free cash flow is one of the most honest signs of a healthy business model.
- Funda Rating (Fundamental Rating A+ to F)
- Our proprietary fundamental rating from 0 to 100 points with a school-grade rank from A+ to F. 50 points is the average across the universe, 100 the best possible score. Every stock is scored against all others by percentile: growth in earnings and revenue, earnings surprises, analyst estimates, and quality criteria such as margins, cash flow, and balance-sheet strength. Grades: A+ from 95, A from 75, B from 55, C from 45, D from 25, E from 5, F below — A/A+ are the fundamentally strongest stocks in the universe.
- Market Capitalization (Mkt Cap)
- The market value of the company: share price x total shares outstanding, shown here in billions of dollars. Micro caps (< $0.3B) are small and volatile, mega caps (> $200B) are heavyweights. Our scanner universe is deliberately capped at $50B - we look for stocks with room to run.
- Net Margin
- How much of revenue is left as profit? Net income divided by revenue, in percent. A 20% margin means: out of every dollar of revenue, 20 cents is left as profit. Rising margins are a strong quality signal.
- Operating Cash Flow (OCF)
- The cash that actually flows into the company from day-to-day operations - without accounting effects such as depreciation. A company can report book profits while still burning cash; operating cash flow reveals that.
- Piotroski F-Score
- A balance-sheet health check developed by Joseph Piotroski: 9 yes/no criteria covering earnings, cash flow, leverage, and efficiency produce a score from 0 to 9. Scores of 7 or higher are considered financially very solid, scores under 3 a warning sign.
- Sector & Industry
- Two levels of industry classification: sector is broad (e.g., Technology), industry is narrow (e.g., Semiconductors). Many strategies watch industry strength, because strong stocks are almost always found in strong industries.
- Stage (Weinstein Stages 1-4)
- Stan Weinstein divides every price chart into four stages: Stage 1 = basing (sideways after a downtrend), Stage 2 = uptrend (the only buying stage), Stage 3 = topping, Stage 4 = downtrend (avoid, or short candidate). Measured against the 30-week line (150-day moving average) and its slope.
- Stress RS (Strength on Stress Days)
- A stress day is a day on which both the overall market and the stock's own sector fell at least 0.5%. Stress RS counts on how many of these days the stock still closed green (shown as "g/n" = green days out of n stress days) and turns that into a rating from 1 to 99. High values point to buyers stepping in even on weak days - often a sign of institutional accumulation.
Hit List
Filter ▾
Rating (traffic light)
Stage
Funda Rating
Piotroski
Columns ▾
This scanner's columns
Extra columns
Tip: clicking a column header sorts the table by that column; a second click flips the direction.
| Symbol | Earnings | Avg/Y 3Y | Stress RS | Stage | Funda Rating | Piotroski | MktCap | Industry | AI Rating | Deep Dive | Deep-Dive Report | Sector | Price | YTD | 6 Mo. | 1 Year | Off High | Price Target | RS | EPS Rating | ADR 10D | ADR 30D | Beta | P/E | P/E (f) | P/S | P/B | P/FCF | PEG | EV/EBITDA | EBIT Margin | Gross Margin | Net Margin | ROE | ROA | Debt/Eq | Equity Ratio | Sales +/Y | Growth Score | Div. Yield | Payout Ratio | Altman Z | Inst. % | Short % | Analysts |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| PRAX Praxis Precision Medicines Inc | 08/03 | +177 % | 96 10/22 | Stage 2 | C 54 | 4 of 9 | 8.5 $ | Biotechnology | – | — | — | Healthcare | 307.80 $ | +3.6 % | +27.6 % | +467.7 % | −10.6 % | +98.2 % | 98 | 42 | 6.8 % | 7.0 % | 2.76 | — | 0.0 | — | 5.7 | — | — | -6.9 | 0.0 % | -3,809.4 % | 0.0 % | -35.3 % | -23.0 % | 0.00 | 96.6 % | -100.0 % | 3 | 0.0 % | 0.0 % | 31.8 | 116.8 % | 13.5 % | 4.4 (12) |
| SLS Sellas Life Sciences Group Inc | 08/11 | +148 % | — | Stage 2 | C 53 | 3 of 9 | 0.0 $ | Biotechnology | Uses AI | — | Healthcare | 10.00 $ | +140.6 % | +444.0 % | +529.6 % | −4.8 % | -5.0 % | 98 | 50 | 12.4 % | 11.1 % | 2.43 | — | 0.0 | — | — | — | — | -1.7 | 0.0 % | — | 0.0 % | -43.6 % | -25.5 % | — | 94.1 % | -100.0 % | 1 | 0.0 % | 0.0 % | 16.0 | 27.6 % | 32.4 % | 1.0 (3) | |
| WYY WidePoint Corporation | 08/13 | +242 % | 92 10/25 | Stage 2 | C 52 | 5 of 9 | 0.1 $ | Information Technology Services | – | — | — | Technology | 10.20 $ | +184.4 % | +194.6 % | +237.9 % | −16.9 % | -3.5 % | 98 | 13 | 16.8 % | 12.9 % | 1.71 | — | 18.2 | 0.6 | — | 13.0 | 2.33 | 117.4 | — | 13.9 % | -1.2 % | -15.8 % | -1.6 % | — | — | +5.6 % | — | 0.0 % | 0.0 % | -0.1 | 18.7 % | 3.5 % | — |
| RVMD Revolution Medicines Inc | 08/05 | +188 % | 38 4/22 | Stage 2 | D 41 | 1 of 9 | 39.0 $ | Biotechnology | – | — | — | Healthcare | 187.50 $ | +112.8 % | +137.2 % | +403.2 % | −3.4 % | +10.4 % | 97 | 42 | 4.8 % | 4.4 % | 1.38 | — | 0.0 | — | 27.2 | — | — | -9.7 | 0.0 % | -151,691.8 % | 0.0 % | -76.7 % | -37.5 % | 0.29 | 66.6 % | -100.0 % | 2 | 0.0 % | 0.0 % | 1.4 | 95.7 % | 7.0 % | 4.7 (12) |
| RLAY Relay Therapeutics Inc | 08/06 | +16 % | 88 8/22 | Stage 2 | D 27 | 3 of 9 | 4.1 $ | Biotechnology | – | — | — | Healthcare | 18.80 $ | +106.1 % | +128.2 % | +434.9 % | −5.9 % | +38.7 % | 97 | 42 | 6.4 % | 8.1 % | 1.68 | — | 0.0 | 379.8 | — | — | — | -0.8 | -2,619.7 % | -2,300.3 % | 0.0 % | -40.0 % | -24.7 % | — | 91.8 % | +53.4 % | 5 | 0.0 % | 0.0 % | 8.5 | 87.0 % | 22.8 % | 4.3 (13) |
| MBX MBX Biosciences, Inc. | 08/06 | — | 69 6/22 | Stage 2 | D 34 | 3 of 9 | 3.0 $ | Biotechnology | Neutral | — | Healthcare | 65.90 $ | +47.1 % | +67.7 % | +397.6 % | −4.1 % | +22.0 % | 97 | 42 | 8.5 % | 7.7 % | — | — | 0.0 | — | 7.2 | — | — | 0.0 | 0.0 % | — | 0.0 % | -25.7 % | -17.7 % | 0.00 | 96.7 % | — | 2 | 0.0 % | 0.0 % | 37.2 | 111.5 % | 17.0 % | 4.6 (5) | |
| BIOA BioAge Labs, Inc | 08/05 | — | — | Stage 2 | C 49 | 4 of 9 | 0.0 $ | Drug Manufacturers - Specialty & Generic | – | — | — | Healthcare | 9.00 $ | +68.7 % | +77.2 % | +105.5 % | −9.3 % | +118.8 % | 97 | 50 | 8.5 % | 7.7 % | — | — | 0.0 | — | 1.2 | — | — | 0.0 | — | -707.2 % | 0.0 % | -26.0 % | -17.2 % | 0.01 | — | -100.0 % | 3 | 0.0 % | 0.0 % | 26.5 | 85.5 % | 5.1 % | — |
| GLUE Monte Rosa Therapeutics Inc | 08/06 | +19 % | — | Stage 2 | D 35 | 4 of 9 | 0.0 $ | Biotechnology | Uses AI | — | Healthcare | 16.50 $ | +32.1 % | +35.5 % | +233.7 % | −16.0 % | +53.1 % | 96 | 50 | 8.1 % | 6.8 % | 1.56 | — | 10.9 | — | 2.5 | — | — | 51.9 | — | -238.5 % | 0.0 % | -32.6 % | -16.4 % | 0.08 | — | +63.5 % | 4 | 0.0 % | 0.0 % | 7.7 | 113.2 % | 20.7 % | — | |
| BLZE Backblaze Inc | 08/06 | +57 % | 62 6/25 | Stage 3 | B 58 | 5 of 9 | 0.8 $ | Software - Infrastructure | Uses AI | — | Technology | 13.70 $ | +150.2 % | +211.9 % | +175.0 % | −8.2 % | +10.7 % | 96 | 42 | 14.6 % | 9.7 % | 1.55 | — | 158.7 | 5.2 | — | 57.1 | — | 131.6 | — | 62.3 % | -15.0 % | -27.6 % | -5.2 % | — | — | +14.3 % | 5 | 0.0 % | 0.0 % | -0.3 | 48.9 % | 4.5 % | 4.8 (6) | |
| ELVN Enliven Therapeutics Inc. | 08/12 | +44 % | 69 6/22 | Stage 2 | D 29 | 4 of 9 | 3.7 $ | Biotechnology | – | — | — | Healthcare | 54.80 $ | +215.6 % | +203.9 % | +191.4 % | −2.8 % | +22.1 % | 95 | 42 | 6.6 % | 6.9 % | 0.26 | — | 0.0 | — | 8.8 | — | — | -6.3 | 0.0 % | — | 0.0 % | -26.6 % | -18.9 % | 0.00 | 97.5 % | — | 2 | 0.0 % | 0.0 % | 47.0 | 89.7 % | 17.7 % | 4.9 (8) |
| NVCT Nuvectis Pharma Inc | 08/04 | +1 % | 82 7/22 | Stage 2 | E 24 | 1 of 9 | 0.7 $ | Biotechnology | – | — | — | Healthcare | 21.50 $ | +132.5 % | +270.0 % | +209.2 % | −0.2 % | +47.9 % | 95 | 42 | 16.4 % | 9.8 % | -0.25 | — | 0.0 | — | — | — | — | -7.4 | — | — | 0.0 % | -154.4 % | -63.6 % | — | — | -100.0 % | 3 | 0.0 % | 0.0 % | -7.1 | 18.2 % | 7.3 % | 4.3 (6) |
| OSCR Oscar Health Inc | 08/05 | +84 % | 79 7/22 | Stage 2 | B 64 | 7 of 9 | 9.0 $ | Healthcare Plans | Uses AI | — | — | Healthcare | 31.20 $ | +108.3 % | +97.3 % | +122.2 % | −5.6 % | -19.2 % | 94 | 87 | 5.6 % | 6.6 % | 2.34 | — | 588.2 | 0.7 | 5.7 | 3.2 | — | 0.0 | 15.2 % | 17.4 % | -0.3 % | -2.6 % | 0.1 % | 0.26 | 17.9 % | +27.5 % | 4 | 0.0 % | 0.0 % | 3.0 | 67.6 % | 8.0 % | 3.3 (7) |
| URGN UroGen Pharma Ltd | 08/06 | +18 % | 69 6/22 | Stage 2 | B 57 | 3 of 9 | 1.8 $ | Biotechnology | Uses AI | — | — | Healthcare | 38.20 $ | +50.1 % | +51.8 % | +100.6 % | −4.7 % | +17.1 % | 94 | 42 | 5.1 % | 5.4 % | 1.58 | — | 0.0 | 13.1 | — | — | — | -2.6 | -39.8 % | 89.9 % | -94.8 % | -1,481.3 % | -27.0 % | — | -49.0 % | +21.5 % | 4 | 0.0 % | 0.0 % | -8.0 | 100.6 % | 11.9 % | 4.4 (8) |
| TMCI Treace Medical Concepts Inc | 08/06 | -28 % | 40 4/22 | Stage 3 | D 33 | 4 of 9 | 0.2 $ | Medical Devices | Neutral | — | Healthcare | 4.30 $ | +83.3 % | +75.0 % | -19.7 % | −42.8 % | -10.1 % | 94 | 42 | 10.5 % | 9.8 % | 1.38 | — | 0.0 | 1.2 | 3.4 | — | — | -40.9 | — | 79.7 % | -29.4 % | -66.9 % | -17.9 % | 0.18 | — | +1.6 % | — | 0.0 % | 0.0 % | 0.4 | 57.1 % | 6.3 % | — | |
| RCUS Arcus Biosciences Inc | 08/05 | +16 % | 40 4/22 | Stage 2 | D 34 | 0 of 9 | 3.5 $ | Biotechnology | Neutral | — | Healthcare | 28.20 $ | +18.3 % | +34.4 % | +208.8 % | −3.8 % | +30.6 % | 93 | 42 | 6.2 % | 6.0 % | 0.80 | — | 0.0 | 15.0 | 6.9 | — | — | 4.0 | -788.2 % | -121.6 % | -156.4 % | -70.0 % | -23.1 % | 0.22 | 52.6 % | -4.3 % | 4 | 0.0 % | 0.0 % | 1.0 | 72.4 % | 16.4 % | 4.5 (13) | |
| CGEM Cullinan Oncology LLC | 08/06 | +14 % | 55 5/22 | Stage 2 | C 47 | 1 of 9 | 1.0 $ | Biotechnology | – | — | — | Healthcare | 16.50 $ | +71.5 % | +79.5 % | +112.4 % | −1.5 % | +91.7 % | 93 | 42 | 8.3 % | 8.2 % | -0.01 | — | 6.7 | — | — | — | — | -1.5 | — | — | 0.0 % | -48.2 % | -30.6 % | — | — | -100.0 % | 3 | 0.0 % | 0.0 % | 10.2 | 107.8 % | 23.8 % | 4.9 (9) |
| JBIO Jade Biosciences, Inc. | 08/12 | -21 % | 55 5/22 | Stage 2 | E 24 | 2 of 9 | 1.1 $ | Biotechnology | – | — | — | Healthcare | 19.80 $ | +42.4 % | +33.8 % | +174.7 % | −22.1 % | +144.9 % | 93 | 42 | 9.6 % | 9.1 % | — | — | 0.0 | — | 4.1 | — | — | 0.0 | — | — | 0.0 % | -89.2 % | -33.6 % | 0.00 | — | — | 2 | 0.0 % | 0.0 % | 18.0 | 84.8 % | 15.3 % | 5.0 (3) |
| INSW International Seaways Inc | 08/05 | +79 % | 79 3/10 | Stage 2 | B 63 | 7 of 9 | 4.7 $ | Oil & Gas Midstream | – | — | — | Energy | 96.20 $ | +102.2 % | +76.8 % | +171.9 % | −12.1 % | -3.3 % | 92 | 95 | 5.0 % | 4.2 % | -0.10 | — | 7.0 | 4.8 | — | 38.6 | — | 6.7 | 61.3 % | 67.7 % | 55.3 % | 26.9 % | 10.5 % | — | 76.4 % | -11.4 % | 5 | 4.1 % | 111.1 % | 11.0 | 80.8 % | 6.2 % | 4.8 (6) |
| MRX Marex Group plc Ordinary Shares | 08/12 | — | 79 7/22 | Stage 2 | B 61 | 4 of 9 | 4.6 $ | Capital Markets | – | — | — | Financial Services | 64.90 $ | +74.6 % | +49.3 % | +70.9 % | −4.8 % | +11.5 % | 92 | 79 | 4.9 % | 4.7 % | -0.09 | 14.7 | 8.8 | 0.8 | 3.5 | — | — | 6.1 | 13.1 % | 68.9 % | 10.6 % | 29.1 % | 1.1 % | — | 3.7 % | +25.4 % | 8 | 1.0 % | 17.1 % | 4.2 | 75.2 % | 5.1 % | 4.3 (8) |
| NAT Nordic American Tankers Limited | — | +50 % | 98 5/10 | Stage 2 | C 54 | 7 of 9 | 1.3 $ | Oil & Gas Midstream | – | — | — | Energy | 6.50 $ | +102.0 % | +83.4 % | +169.1 % | −6.6 % | -7.7 % | 92 | 97 | 5.9 % | 4.4 % | -0.55 | — | 14.0 | 3.9 | — | — | 1.21 | 18.9 | 49.5 % | 46.9 % | 16.4 % | 11.4 % | 4.7 % | — | 50.6 % | -16.4 % | 3 | 13.5 % | 2.8 % | 6.0 | 50.0 % | 8.2 % | 3.7 (3) |
| KGS Kodiak Gas Services, Inc. | 08/05 | — | 98 5/10 | Stage 2 | B 56 | 7 of 9 | 5.8 $ | Oil & Gas Equipment & Services | – | — | — | Energy | 58.70 $ | +94.9 % | +106.1 % | +89.8 % | −4.8 % | +42.3 % | 91 | 17 | 4.1 % | 3.8 % | 0.82 | 73.8 | 26.0 | 4.4 | 5.1 | 29.2 | — | 15.3 | 33.7 % | 64.2 % | 5.1 % | 5.4 % | 6.0 % | 0.06 | 26.1 % | +12.8 % | 7 | 3.3 % | 1.8 % | 4.2 | 91.3 % | 9.5 % | 4.4 (11) |
| OMER Omeros Corporation | 08/13 | -8 % | 80 7/22 | Stage 1 | B 66 | 6 of 9 | 0.9 $ | Biotechnology | – | — | — | Healthcare | 11.80 $ | -39.0 % | -35.5 % | +205.9 % | −39.3 % | +179.7 % | 91 | 42 | 10.1 % | 8.1 % | 2.55 | 8.4 | 58.1 | 86.5 | 9.3 | — | 0.81 | -1.5 | — | -190.5 % | 871.0 % | -576.3 % | -25.2 % | -4.91 | — | -100.0 % | 3 | 0.0 % | 0.0 % | -1.8 | 44.5 % | 21.6 % | 4.0 (4) |
| ALKS Alkermes Plc | 08/04 | +15 % | 68 6/22 | Stage 2 | C 53 | 1 of 9 | 8.2 $ | Drug Manufacturers - Specialty & Generic | – | — | — | Healthcare | 49.00 $ | +71.8 % | +84.2 % | +84.9 % | −1.6 % | +14.3 % | 90 | 9 | 4.8 % | 4.2 % | 0.29 | 56.8 | 133.3 | 4.9 | 4.9 | 36.8 | 1.96 | 41.9 | -0.2 % | 87.2 % | 4.0 % | 9.4 % | 4.2 % | 0.90 | 41.1 % | -5.3 % | 5 | 0.0 % | 0.0 % | 4.9 | 110.5 % | 12.5 % | 4.1 (15) |
| INDV Indivior Pharmaceuticals, Inc. | 07/30 | +25 % | 68 6/22 | Stage 2 | B 61 | 4 of 9 | 4.5 $ | Drug Manufacturers - Specialty & Generic | Neutral | — | Healthcare | 40.00 $ | +11.4 % | +14.1 % | +98.1 % | −1.9 % | +27.1 % | 90 | 83 | 3.6 % | 3.6 % | 1.15 | 20.8 | 13.0 | 3.5 | 140.7 | — | — | 14.3 | 46.1 % | 85.0 % | 19.5 % | 12.2 % | 22.7 % | -3.49 | -12.0 % | +4.3 % | 4 | 0.0 % | 0.0 % | 3.6 | 107.5 % | 11.3 % | 4.7 (7) | |
| CLPT Clearpoint Neuro Inc | 08/11 | +61 % | 40 4/22 | Stage 3 | D 44 | 4 of 9 | 0.5 $ | Medical Devices | Neutral | — | — | Healthcare | 14.90 $ | +35.5 % | +34.1 % | +43.7 % | −40.3 % | +90.2 % | 90 | 42 | 11.6 % | 9.0 % | 1.24 | — | 12.1 | 11.1 | 23.8 | — | 0.61 | -7.1 | — | 62.3 % | -71.6 % | -149.7 % | -25.0 % | 3.38 | — | +17.8 % | — | 0.0 % | 0.0 % | -3.1 | 50.6 % | 12.8 % | 5.0 (2) |
| HSHP Himalaya Shipping Ltd. | 08/14 | +61 % | 90 11/29 | Stage 2 | B 63 | 7 of 9 | 0.7 $ | Marine Shipping | – | — | — | Industrials | 15.70 $ | +71.0 % | +58.7 % | +159.1 % | −17.9 % | +5.1 % | 90 | 97 | 4.0 % | 3.9 % | 0.96 | — | 9.2 | 5.2 | — | 12.2 | — | 12.8 | — | 78.8 % | 20.3 % | 18.3 % | 5.7 % | — | — | +6.7 % | 7 | 8.3 % | 108.4 % | 4.3 | 47.7 % | 3.5 % | 4.0 (1) |
| ZURA Zura Bio Limited Class A Ordinary Shares | 08/13 | -21 % | 42 4/22 | Stage 1 | D 32 | 3 of 9 | 0.5 $ | Biotechnology | – | — | — | Healthcare | 5.40 $ | -17.8 % | +25.1 % | +287.9 % | −39.0 % | +207.4 % | 90 | 42 | 9.7 % | 8.0 % | -0.04 | — | 0.0 | — | — | — | — | -2.3 | — | — | 0.0 % | -41.0 % | -25.4 % | — | — | — | 3 | 0.0 % | 0.0 % | 23.1 | 78.6 % | 14.5 % | 4.6 (7) |
| LGND Ligand Pharmaceuticals Incorporated | 08/06 | +94 % | 54 5/22 | Stage 2 | B 58 | 5 of 9 | 5.4 $ | Biotechnology | – | — | — | Healthcare | 287.50 $ | +47.8 % | +59.3 % | +118.5 % | −1.4 % | +12.5 % | 89 | 86 | 5.6 % | 4.1 % | 0.98 | 38.4 | 32.3 | 19.7 | 5.9 | 43.9 | 1.53 | 24.2 | 33.6 % | 83.2 % | 56.0 % | 17.1 % | 5.2 % | 0.51 | 65.1 % | +60.4 % | 7 | 0.0 % | 0.0 % | 10.8 | 106.4 % | 11.5 % | 4.6 (7) |
| ASTH Astrana Health Inc | 08/06 | +13 % | 70 6/22 | Stage 2 | B 62 | 5 of 9 | 1.8 $ | Medical Care Facilities | Uses AI | — | Healthcare | 35.60 $ | +66.1 % | +79.3 % | +49.0 % | −0.5 % | +38.6 % | 89 | 87 | 3.6 % | 3.8 % | 0.89 | — | 23.0 | 0.5 | — | 11.4 | — | 14.4 | 3.0 % | 10.7 % | 0.9 % | 5.7 % | 3.6 % | — | 33.9 % | +56.4 % | 5 | 0.0 % | 0.0 % | 5.2 | 61.5 % | 10.3 % | 4.5 (12) | |
| WTTR Select Energy Services Inc | 08/04 | +56 % | 56 2/10 | Stage 2 | C 52 | 6 of 9 | 2.6 $ | Oil & Gas Equipment & Services | – | — | — | Energy | 18.50 $ | +78.1 % | +85.5 % | +97.0 % | −6.4 % | +21.6 % | 89 | 30 | 3.5 % | 3.8 % | 0.96 | 88.0 | 23.5 | 1.8 | 2.3 | — | — | 10.7 | 6.5 % | 28.1 % | 1.5 % | 2.1 % | 1.7 % | 0.29 | 58.1 % | -3.1 % | 4 | 1.5 % | 120.7 % | 5.6 | 97.7 % | 5.0 % | 5.0 (5) |
| NUVB Nuvation Bio Inc | 08/06 | +81 % | 69 6/22 | Stage 2 | B 67 | 6 of 9 | 2.1 $ | Biotechnology | – | — | — | Healthcare | 6.30 $ | -32.6 % | -41.1 % | +168.2 % | −40.4 % | +102.8 % | 89 | 42 | 7.2 % | 7.6 % | 1.53 | — | 0.0 | 14.7 | 7.6 | — | — | 2.2 | 4.7 % | 90.8 % | -102.1 % | -39.5 % | -17.0 % | 0.03 | 52.4 % | +699.0 % | 5 | 0.0 % | 0.0 % | 2.5 | 64.9 % | 26.5 % | 4.6 (7) |
| CARE Carter Bank and Trust | 07/23 | +38 % | 69 6/22 | Stage 2 | B 62 | 7 of 9 | 0.8 $ | Banks - Regional | Neutral | — | Financial Services | 34.60 $ | +65.1 % | +68.4 % | +99.7 % | −1.1 % | -8.0 % | 89 | 96 | 2.7 % | 2.8 % | 0.51 | — | 13.7 | 2.4 | — | 2.4 | — | 0.0 | — | 100.0 % | 44.9 % | 23.9 % | 2.7 % | — | — | +6.2 % | 6 | 1.2 % | 12.5 % | -1.9 | 59.2 % | 8.6 % | 4.7 (3) | |
| PBYI Puma Biotechnology, Inc. | 08/06 | +42 % | 42 4/22 | Stage 2 | D 44 | 7 of 9 | 0.4 $ | Biotechnology | Neutral | — | Healthcare | 7.90 $ | +34.1 % | +16.3 % | +155.0 % | −7.0 % | -36.7 % | 89 | 19 | 5.0 % | 4.1 % | 1.19 | 16.5 | 3.5 | 1.8 | 3.2 | 7.5 | 0.03 | 7.1 | -8.5 % | 74.5 % | 10.7 % | 21.6 % | 9.5 % | 0.18 | 60.3 % | -0.9 % | — | 0.0 % | 0.0 % | -3.4 | 75.0 % | 9.0 % | 3.0 (1) | |
| CYTK Cytokinetics Inc | 08/06 | +8 % | 68 6/22 | Stage 2 | D 39 | 3 of 9 | 10.4 $ | Biotechnology | Neutral | — | Healthcare | 77.10 $ | +25.9 % | +36.0 % | +104.9 % | −2.6 % | +39.8 % | 88 | 42 | 4.6 % | 4.1 % | 0.42 | — | 117.6 | 97.8 | 57.5 | — | — | -15.8 | -948.7 % | -290.7 % | 0.0 % | -572.2 % | -31.5 % | -1.56 | -64.9 % | +376.6 % | 3 | 0.0 % | 0.0 % | -7.3 | 118.8 % | 19.4 % | 4.3 (21) | |
| LFST Lifestance Health Group Inc | 08/06 | +2 % | 40 4/22 | Stage 2 | B 73 | 8 of 9 | 4.0 $ | Medical Care Facilities | Threatened | — | Healthcare | 10.50 $ | +34.1 % | +45.8 % | +163.3 % | −1.2 % | +14.3 % | 88 | 98 | 4.1 % | 3.7 % | 1.12 | 172.0 | 69.9 | 2.6 | 2.6 | 22.2 | — | 43.4 | 5.5 % | 32.6 % | 1.6 % | 1.6 % | 1.4 % | 0.13 | 68.9 % | +13.9 % | 6 | 0.0 % | 0.0 % | 4.9 | 88.6 % | 5.1 % | 4.5 (8) | |
| MAMA Mama's Creations Inc. | — | +181 % | — | Stage 2 | B 72 | 5 of 9 | 0.9 $ | Packaged Foods | Neutral | — | Consumer Defensive | 18.40 $ | +31.5 % | +19.1 % | +123.1 % | −14.1 % | +21.9 % | 88 | 50 | 6.2 % | 5.6 % | 0.56 | 122.7 | 76.9 | 4.5 | 15.2 | 94.2 | — | 59.7 | 5.1 % | 24.5 % | 3.2 % | 14.9 % | 8.5 % | 0.14 | 61.4 % | +39.2 % | 5 | 0.0 % | 0.0 % | 17.7 | 69.4 % | 7.0 % | 4.5 (4) | |
| TDAY USA TODAY Co., Inc. | 07/30 | +94 % | — | Stage 2 | C 49 | 6 of 9 | 0.0 $ | Publishing | – | — | — | Communication Services | 8.70 $ | +55.7 % | +61.4 % | +128.1 % | −4.1 % | +7.2 % | 88 | 50 | 3.6 % | 3.8 % | 1.40 | 46.2 | 15.1 | — | 8.6 | — | 0.94 | 8.1 | — | 39.4 % | 1.3 % | 19.9 % | 4.7 % | 7.98 | — | -8.3 % | 3 | 0.0 % | 0.0 % | 1.6 | 96.0 % | 11.9 % | — |
| PTGX Protagonist Therapeutics Inc | 08/05 | +110 % | 53 5/22 | Stage 2 | C 47 | 6 of 9 | 8.8 $ | Biotechnology | – | — | — | Healthcare | 136.60 $ | +36.2 % | +36.9 % | +153.7 % | −2.8 % | -2.4 % | 87 | 94 | 4.2 % | 4.5 % | 1.79 | — | 28.9 | 118.4 | 13.4 | — | — | 244.6 | -6.5 % | 100.0 % | -154.9 % | -17.1 % | -12.4 % | 0.02 | 94.0 % | -89.4 % | 4 | 0.0 % | 0.0 % | 21.8 | 125.3 % | 15.0 % | 4.4 (10) |
| AMRX Amneal Pharmaceuticals, Inc. | 08/04 | +160 % | 54 5/22 | Stage 2 | B 64 | 5 of 9 | 5.8 $ | Drug Manufacturers - Specialty & Generic | – | — | — | Healthcare | 18.30 $ | +32.2 % | +34.3 % | +134.3 % | −2.6 % | +10.7 % | 87 | 94 | 3.6 % | 3.6 % | 1.26 | 49.2 | 6.3 | 1.9 | 111.4 | 28.4 | — | 13.7 | 19.6 % | 39.8 % | 5.1 % | -881.3 % | 8.7 % | -59.38 | -1.3 % | +8.1 % | 4 | 0.0 % | 0.0 % | 5.6 | 52.2 % | 3.8 % | 4.3 (4) |
| VIR Vir Biotechnology Inc | 08/05 | -20 % | 39 4/22 | Stage 2 | D 27 | 2 of 9 | 1.4 $ | Biotechnology | – | — | — | Healthcare | 8.70 $ | +68.5 % | +69.9 % | +70.8 % | −15.3 % | +147.8 % | 87 | 80 | 5.4 % | 5.1 % | 1.62 | — | 4.3 | 21.1 | 1.8 | — | — | 0.9 | — | -566.8 % | 0.0 % | -47.7 % | -24.8 % | 0.12 | — | -7.6 % | 3 | 0.0 % | 0.0 % | 3.0 | 81.6 % | 11.1 % | 4.0 (9) |
| MNPR Monopar Therapeutics Inc | 08/11 | -10 % | 89 8/22 | Stage 3 | D 32 | 4 of 9 | 0.6 $ | Biotechnology | Neutral | — | Healthcare | 108.40 $ | +25.2 % | +33.6 % | +163.1 % | −16.5 % | +7.8 % | 87 | 42 | 8.6 % | 7.6 % | 1.48 | — | 0.0 | — | 5.4 | — | — | -2.4 | — | — | 0.0 % | -15.9 % | -12.1 % | 0.00 | — | -100.0 % | 4 | 0.0 % | 0.0 % | 62.2 | 93.3 % | 29.7 % | 4.2 (5) | |
| ORMP Oramed Pharmaceuticals Inc | 08/13 | +13 % | 71 6/22 | Stage 2 | C 47 | 3 of 9 | 0.2 $ | Biotechnology | – | — | — | Healthcare | 4.10 $ | +56.9 % | +58.0 % | +103.1 % | −3.7 % | +25.0 % | 87 | 75 | 7.3 % | 6.4 % | 1.20 | 1.5 | 0.0 | — | 0.7 | — | — | 1.6 | — | — | 0.0 % | 58.2 % | -4.3 % | 0.00 | — | -100.0 % | — | 5.4 % | 9.6 % | 13.8 | 37.1 % | 1.7 % | — |
| MSGE Madison Square Garden Entertainment Corp. | 08/12 | +45 % | 35 4/24 | Stage 2 | B 56 | 6 of 9 | 3.6 $ | Entertainment | Neutral | — | Communication Services | 77.30 $ | +41.8 % | +48.6 % | +104.5 % | −0.6 % | +4.4 % | 86 | 18 | 4.0 % | 3.0 % | 0.55 | 72.8 | 27.5 | 3.5 | 77.6 | 11.0 | — | 25.2 | 10.3 % | 46.9 % | 4.8 % | 170.3 % | 5.0 % | 0.08 | 53.2 % | -1.7 % | 3 | 0.0 % | 0.0 % | 4.1 | 102.1 % | 3.8 % | 4.4 (9) | |
| MIRM Mirum Pharmaceuticals Inc | 08/05 | +102 % | 68 6/22 | Stage 2 | C 45 | 3 of 9 | 6.3 $ | Biotechnology | – | — | — | Healthcare | 106.00 $ | +40.6 % | +52.3 % | +105.0 % | −1.9 % | +38.2 % | 86 | 42 | 5.0 % | 5.0 % | 0.49 | — | 39.7 | 11.0 | 28.1 | — | — | 341.2 | -39.5 % | 81.4 % | -140.2 % | -335.8 % | -5.9 % | 1.34 | 27.2 % | +54.7 % | 7 | 0.0 % | 0.0 % | -5.4 | 114.4 % | 15.6 % | 4.6 (10) |
| PRSU Pursuit Attractions and Hospitality, Inc. | 08/05 | +41 % | — | Stage 2 | D 42 | 5 of 9 | 0.0 $ | Travel Services | – | — | — | Consumer Cyclical | 50.50 $ | +54.9 % | +58.9 % | +67.1 % | −0.7 % | +7.0 % | 86 | 50 | 3.2 % | 2.9 % | 1.35 | 47.7 | 35.1 | — | 2.7 | — | 2.34 | 14.7 | — | 92.4 % | 6.2 % | 7.5 % | 5.1 % | 0.43 | — | +23.5 % | 4 | 0.0 % | 0.0 % | 5.7 | 111.6 % | 7.2 % | — |
| ADV Advantage Solutions Inc | 08/06 | -10 % | 97 11/24 | Stage 2 | D 35 | 4 of 9 | 0.5 $ | Advertising Agencies | – | — | — | Communication Services | 39.20 $ | +81.0 % | +112.3 % | +14.6 % | −10.0 % | +8.4 % | 86 | 29 | 9.4 % | 8.9 % | 2.09 | — | 0.0 | 0.1 | 1.1 | 8.4 | — | 24.7 | — | 14.0 % | -6.8 % | -41.5 % | 2.3 % | 3.24 | — | -0.7 % | 5 | 0.0 % | 0.0 % | 0.4 | 30.8 % | 10.2 % | 3.7 (3) |
| DHT DHT Holdings Inc | 08/05 | +71 % | 98 5/10 | Stage 2 | B 59 | 6 of 9 | 3.0 $ | Oil & Gas Midstream | – | — | — | Energy | 18.60 $ | +73.7 % | +49.8 % | +84.3 % | −12.0 % | +8.6 % | 85 | 92 | 5.4 % | 4.0 % | -0.13 | — | 5.4 | 5.2 | — | — | 1.19 | 7.5 | 68.0 % | 70.8 % | 50.3 % | 28.9 % | 13.2 % | — | 69.1 % | -13.0 % | 5 | 13.8 % | 110.5 % | 7.3 | 81.4 % | 7.1 % | 4.8 (6) |
| UFCS United Fire Group Inc | 08/04 | +48 % | 69 6/22 | Stage 2 | B 59 | 6 of 9 | 1.3 $ | Insurance - Property & Casualty | Threatened | — | Financial Services | 51.40 $ | +41.2 % | +45.7 % | +97.3 % | −4.8 % | -0.8 % | 84 | 82 | 3.2 % | 3.2 % | 0.50 | 10.4 | 14.1 | 0.9 | 1.3 | 4.6 | 1.41 | 0.0 | 11.2 % | 12.4 % | 9.2 % | 14.8 % | 3.0 % | 0.16 | 24.5 % | +10.8 % | 7 | 1.6 % | 17.3 % | 0.9 | 69.0 % | 1.7 % | 4.0 (2) | |
| ASC Ardmore Shpng | 07/29 | +22 % | 85 10/29 | Stage 2 | C 53 | 7 of 9 | 0.7 $ | Marine Shipping | – | — | — | Industrials | 17.40 $ | +74.0 % | +38.4 % | +67.0 % | −20.5 % | +17.8 % | 84 | 93 | 5.3 % | 4.3 % | 0.02 | — | 3.4 | 2.2 | — | — | — | 4.5 | — | 45.3 % | 29.7 % | 9.0 % | 9.0 % | — | — | -23.6 % | 5 | 7.9 % | 58.3 % | 10.7 | 83.4 % | 6.2 % | 5.0 (3) |
| USIO Usio Inc | 08/05 | +5 % | 62 6/25 | Stage 2 | C 52 | 8 of 9 | 0.1 $ | Software - Infrastructure | – | — | — | Technology | 2.10 $ | +45.6 % | +66.9 % | +24.6 % | −3.6 % | +159.7 % | 84 | 11 | 7.2 % | 7.4 % | 1.30 | — | 45.7 | 0.7 | 3.3 | — | 0.95 | 316.2 | — | 22.5 % | -2.4 % | -11.6 % | -1.0 % | 0.20 | — | +3.0 % | — | 0.0 % | 0.0 % | 1.9 | 25.0 % | 0.2 % | — |
| SB Safe Bulkers Inc | 08/04 | +50 % | 96 13/29 | Stage 2 | C 54 | 7 of 9 | 0.8 $ | Marine Shipping | – | — | — | Industrials | 7.80 $ | +49.7 % | +33.5 % | +106.6 % | −10.6 % | -0.2 % | 83 | 92 | 5.0 % | 4.3 % | 0.85 | — | 2.1 | 2.7 | — | 36.2 | 3.33 | 6.7 | — | 63.6 % | 28.3 % | 6.4 % | 4.5 % | — | — | -10.4 % | 4 | 3.8 % | 33.3 % | — | 37.9 % | 6.2 % | 5.0 (2) |
| FVR FrontView REIT, Inc. | 08/12 | — | 31 3/21 | Stage 2 | B 55 | 9 of 9 | 0.5 $ | REIT - Diversified | – | — | — | Real Estate | 20.30 $ | +37.4 % | +35.7 % | +82.6 % | −3.6 % | +5.1 % | 83 | 42 | 3.8 % | 3.2 % | — | — | 0.0 | 6.7 | 1.1 | 11.2 | — | 15.7 | — | 85.6 % | -3.9 % | -0.7 % | 1.0 % | 0.78 | — | +12.0 % | — | 4.2 % | 488.2 % | 4.5 | 90.3 % | 9.6 % | 4.2 (5) |
| TNK Teekay Tankers Ltd | 07/29 | +45 % | 93 4/10 | Stage 2 | B 55 | 7 of 9 | 2.7 $ | Oil & Gas Midstream | Neutral | — | — | Energy | 79.40 $ | +50.7 % | +24.6 % | +92.4 % | −16.3 % | +12.6 % | 82 | 86 | 4.8 % | 4.0 % | -0.25 | 6.5 | 5.0 | 2.7 | 1.3 | 19.9 | 1.10 | 2.3 | 43.7 % | 50.3 % | 51.3 % | 21.4 % | 12.0 % | 0.02 | 91.6 % | -22.6 % | 4 | 1.3 % | 12.9 % | 20.2 | 70.5 % | 3.9 % | 4.3 (6) |
| IRM Iron Mountain Incorporated | 08/05 | +58 % | 84 7/21 | Stage 2 | B 67 | 7 of 9 | 36.4 $ | REIT - Specialty | – | — | — | Real Estate | 122.30 $ | +62.8 % | +62.0 % | +29.9 % | −2.7 % | +8.6 % | 81 | 96 | 3.3 % | 2.8 % | 1.22 | 132.9 | 61.0 | 5.0 | 1,415.1 | — | 2.70 | 23.9 | 21.0 % | 55.0 % | 3.8 % | 225.1 % | 4.6 % | -3.04 | -5.7 % | +12.2 % | 4 | 2.8 % | 133.5 % | 2.6 | 87.9 % | 3.8 % | 4.3 (11) |
| RPRX Royalty Pharma Plc | 08/05 | +31 % | 92 9/22 | Stage 2 | B 62 | 6 of 9 | 32.2 $ | Biotechnology | – | — | — | Healthcare | 58.40 $ | +44.6 % | +46.9 % | +62.2 % | −3.2 % | +2.5 % | 81 | 68 | 2.9 % | 2.5 % | 0.42 | 31.6 | 48.3 | 13.2 | 3.9 | 12.1 | 2.19 | 19.7 | 100.3 % | 115.0 % | 33.9 % | 13.8 % | 5.5 % | 1.50 | 34.8 % | +5.1 % | 5 | 1.6 % | 23.5 % | 5.3 | 88.1 % | 2.8 % | 4.3 (8) |
| CMPR Cimpress NV | 08/04 | +22 % | 67 8/29 | Stage 2 | C 46 | 6 of 9 | 2.4 $ | Specialty Business Services | – | — | — | Industrials | 98.70 $ | +31.9 % | +39.5 % | +78.5 % | −15.5 % | +12.0 % | 81 | 24 | 4.8 % | 4.4 % | 1.79 | — | 20.5 | 0.6 | — | 12.7 | 2.38 | 9.5 | 5.9 % | 46.3 % | 2.6 % | 0.0 % | 7.7 % | — | -25.5 % | +3.4 % | 6 | 0.0 % | 0.0 % | 3.5 | 90.2 % | 14.4 % | 4.5 (2) |
| TK Teekay Corporation Ltd. | 07/29 | +97 % | 80 3/10 | Stage 2 | B 66 | 5 of 9 | 1.0 $ | Oil & Gas Midstream | Uses AI | — | Energy | 11.70 $ | +26.8 % | +17.3 % | +76.2 % | −19.1 % | -57.3 % | 81 | 85 | 4.8 % | 4.0 % | 0.13 | 10.2 | 9.6 | 1.0 | 1.4 | — | 1.49 | 0.1 | 43.7 % | 50.4 % | 15.8 % | 17.2 % | 11.3 % | 0.03 | 30.2 % | -22.2 % | 4 | 10.1 % | 65.4 % | 3.6 | 53.3 % | 6.1 % | — | |
| FSBC Five Star Bancorp | 07/22 | +45 % | 55 5/22 | Stage 2 | B 70 | 7 of 9 | 1.0 $ | Banks - Regional | Uses AI | — | — | Financial Services | 47.20 $ | +32.4 % | +33.0 % | +60.8 % | −1.1 % | +8.1 % | 81 | 75 | 3.0 % | 2.7 % | 0.51 | 14.9 | 0.0 | 3.7 | 2.2 | 13.2 | — | 0.0 | — | 100.0 % | 43.0 % | 15.5 % | 1.5 % | 0.19 | — | +20.4 % | 9 | 2.1 % | 28.1 % | -1.4 | 59.3 % | 4.0 % | 4.3 (4) |
| WST West Pharmaceutical Services Inc | 07/23 | -3 % | 78 7/22 | Stage 2 | B 69 | 7 of 9 | 23.6 $ | Medical Instruments & Supplies | Neutral | — | Healthcare | 341.00 $ | +22.5 % | +28.4 % | +43.0 % | −1.6 % | +18.7 % | 80 | 79 | 2.3 % | 2.6 % | 1.16 | 46.2 | 38.6 | 7.1 | 8.2 | 54.0 | 2.93 | 27.1 | 21.7 % | 36.8 % | 17.0 % | 19.1 % | 11.4 % | 0.11 | 72.8 % | +6.3 % | 5 | 0.3 % | 10.4 % | 12.5 | 103.9 % | 3.9 % | 4.7 (13) | |
| LTH Life Time Group Holdings Inc | 08/04 | +33 % | 42 6/31 | Stage 2 | B 64 | 8 of 9 | 9.9 $ | Leisure | – | — | — | Consumer Cyclical | 45.10 $ | +42.3 % | +54.7 % | +57.0 % | −1.9 % | +6.7 % | 80 | 62 | 4.1 % | 3.8 % | 1.51 | 26.4 | 28.2 | 3.1 | 3.0 | — | — | 16.3 | 17.1 % | 48.0 % | 13.0 % | 13.0 % | 4.3 % | 2.09 | 39.7 % | +14.3 % | 7 | 0.0 % | 0.0 % | 4.2 | 88.8 % | 6.2 % | 4.4 (13) |
| WLFC Willis Lease Finance Corporation | 08/04 | +149 % | 59 7/29 | Stage 2 | B 63 | 6 of 9 | 1.7 $ | Rental & Leasing Services | Neutral | — | — | Industrials | 71.30 $ | +55.8 % | +65.6 % | +52.4 % | −7.1 % | +5.7 % | 80 | 77 | 4.7 % | 4.4 % | 0.72 | — | 6.9 | 2.2 | — | — | 0.94 | 9.3 | — | 83.7 % | 16.2 % | 17.6 % | 5.1 % | — | — | +18.7 % | 5 | 0.8 % | 12.6 % | 5.2 | 47.3 % | 16.1 % | 5.0 (1) |
| OOMA Ooma Inc | 08/25 | +8 % | 95 11/25 | Stage 2 | B 60 | 5 of 9 | 0.6 $ | Software - Application | – | — | — | Technology | 21.80 $ | +54.0 % | +68.2 % | +91.1 % | −20.1 % | +5.5 % | 80 | 42 | 4.5 % | 5.0 % | 1.20 | — | 16.4 | 2.0 | — | 23.8 | 1.82 | 26.8 | — | 61.3 % | 3.2 % | 10.0 % | 3.0 % | — | — | +6.5 % | 3 | 0.0 % | 0.0 % | 2.3 | 70.0 % | 4.6 % | 4.7 (7) |
| ENTA Enanta Pharmaceuticals Inc | 08/10 | -22 % | 89 8/22 | Stage 2 | D 42 | 5 of 9 | 0.3 $ | Biotechnology | – | — | — | Healthcare | 12.60 $ | -10.8 % | -12.6 % | +66.2 % | −21.6 % | +68.0 % | 80 | 10 | 6.3 % | 6.1 % | 0.97 | — | 44.1 | 5.0 | — | — | — | 41.1 | — | 100.0 % | -89.6 % | -59.0 % | -11.8 % | — | — | -3.4 % | — | 0.0 % | 0.0 % | 1.1 | 92.8 % | 10.1 % | 3.7 (6) |
| NGS Natural Gas Services Group Inc | 08/10 | +119 % | 58 2/10 | Stage 2 | B 60 | 4 of 9 | 0.5 $ | Oil & Gas Equipment & Services | Uses AI | — | Energy | 36.70 $ | +32.0 % | +26.6 % | +54.3 % | −17.4 % | +51.7 % | 80 | 74 | 3.7 % | 4.0 % | 0.40 | 21.3 | 11.9 | 2.8 | 1.8 | — | 0.82 | 8.6 | 27.7 % | 58.8 % | 12.2 % | 8.1 % | 5.0 % | 0.84 | 46.8 % | +9.9 % | 6 | 1.0 % | 30.9 % | 2.0 | 92.4 % | 3.4 % | 4.8 (4) | |
| FLNT Fluent Inc | 08/18 | -2 % | 94 10/24 | Stage 2 | C 45 | 5 of 9 | 0.1 $ | Advertising Agencies | – | — | — | Communication Services | 3.40 $ | +41.3 % | +44.9 % | +48.9 % | −21.9 % | +31.2 % | 79 | 99 | 10.1 % | 10.9 % | 0.74 | — | 65.4 | 0.5 | 7.6 | — | 1.81 | -3.9 | — | 25.1 % | -12.2 % | -137.3 % | -14.1 % | 2.33 | — | -18.0 % | — | 0.0 % | 0.0 % | -18.8 | 33.4 % | 1.8 % | — |
| SFL SFL Corporation Ltd | 08/18 | +23 % | 90 11/29 | Stage 2 | C 48 | 3 of 9 | 1.5 $ | Marine Shipping | Neutral | — | Industrials | 12.30 $ | +52.6 % | +42.1 % | +46.6 % | −6.9 % | +0.6 % | 78 | 6 | 3.6 % | 2.8 % | 0.47 | 51.3 | 163.9 | 2.2 | 1.7 | 8.2 | — | 9.4 | 25.9 % | 58.5 % | 4.5 % | 3.1 % | 2.9 % | 2.67 | 26.4 % | -19.3 % | 5 | 7.1 % | 4.3 % | 0.5 | 42.7 % | 3.1 % | 4.0 (4) | |
| LQDT Liquidity Services Inc | 08/06 | +49 % | 74 9/31 | Stage 2 | B 57 | 7 of 9 | 1.2 $ | Internet Retail | – | — | — | Consumer Cyclical | 39.00 $ | +26.8 % | +26.7 % | +63.2 % | −3.6 % | +12.8 % | 78 | 54 | 3.1 % | 2.9 % | 1.08 | — | 24.5 | 2.5 | — | 15.7 | 1.78 | 20.2 | — | 46.7 % | 6.3 % | 14.5 % | 6.7 % | — | — | +31.2 % | 8 | 0.0 % | 0.0 % | 7.1 | 80.2 % | 4.8 % | 4.5 (2) |
| WNC Wabash National Corporation | 07/24 | -16 % | 49 6/29 | Stage 2 | D 38 | 2 of 9 | 0.5 $ | Farm & Heavy Construction Machinery | – | — | — | Industrials | 12.60 $ | +48.3 % | +56.9 % | +30.2 % | −0.6 % | +78.6 % | 78 | 97 | 9.6 % | 6.9 % | 1.42 | — | 8.6 | 0.3 | 1.6 | — | 0.73 | 2.0 | — | 1.0 % | -5.5 % | -17.8 % | -3.2 % | 1.66 | — | -20.8 % | 5 | 2.6 % | 6.3 % | 4.6 | 100.8 % | 9.6 % | 4.0 (2) |
| CZWI Citizens Community Bancorp Inc | 07/27 | +59 % | 41 4/22 | Stage 2 | B 59 | 9 of 9 | 0.2 $ | Banks - Regional | – | — | — | Financial Services | 22.00 $ | +29.9 % | +31.3 % | +50.8 % | −1.6 % | +5.2 % | 78 | 11 | 4.0 % | 3.8 % | 0.51 | — | 10.7 | 2.3 | — | 16.7 | — | 0.0 | — | 100.0 % | 24.4 % | 8.1 % | 0.8 % | — | — | -9.4 % | — | 0.9 % | 13.7 % | 4.1 | 61.3 % | 1.0 % | — |
| PRCH Porch Group Inc | 08/04 | +319 % | 81 7/22 | Stage 3 | C 54 | 5 of 9 | 1.5 $ | Insurance - Property & Casualty | – | — | — | Financial Services | 14.50 $ | +41.3 % | +61.7 % | +14.5 % | −33.5 % | +33.9 % | 77 | 42 | 7.1 % | 6.4 % | 3.12 | — | 476.2 | 2.9 | — | 19.3 | — | 26.3 | 9.7 % | 72.1 % | -2.6 % | -15,311.0 % | 3.2 % | — | -3.2 % | +10.2 % | 8 | 0.0 % | 0.0 % | 0.8 | 79.1 % | 22.0 % | 4.6 (5) |
| ALRS Alerus Financial Corp | 07/27 | +29 % | — | Stage 2 | B 61 | 8 of 9 | 0.0 $ | Banks - Regional | – | — | — | Financial Services | 33.30 $ | +36.1 % | +43.1 % | +63.0 % | −1.0 % | -2.9 % | 77 | 50 | 2.3 % | 2.3 % | 0.70 | 29.9 | 0.0 | — | 1.4 | — | — | 0.0 | — | 100.0 % | 11.5 % | 5.0 % | 0.5 % | 0.53 | — | -3.1 % | 2 | 2.7 % | 26.8 % | 3.5 | 64.6 % | 3.0 % | — |
| SOTK Sono-Tek Corp | 07/09 | -1 % | 83 8/25 | Stage 2 | B 62 | 7 of 9 | 0.1 $ | Scientific & Technical Instruments | – | — | — | Technology | 5.20 $ | +29.5 % | +31.2 % | +56.2 % | −12.0 % | +48.5 % | 77 | 77 | 5.8 % | 6.5 % | -0.05 | 49.8 | 0.0 | 3.7 | 4.2 | 13.6 | — | 30.8 | — | 50.5 % | 8.6 % | 9.6 % | 4.6 % | — | — | +2.0 % | — | 0.0 % | 0.0 % | 12.2 | 43.4 % | 0.1 % | — |
| GKOS Glaukos Corp | 07/29 | +33 % | 68 6/22 | Stage 2 | B 56 | 3 of 9 | 9.7 $ | Medical Devices | – | — | — | Healthcare | 166.70 $ | +19.3 % | +21.9 % | +93.7 % | −3.7 % | +16.1 % | 76 | 98 | 3.9 % | 5.6 % | 0.75 | — | 2,000.0 | 15.9 | 14.6 | — | 1.64 | -57.9 | -13.2 % | 79.1 % | -30.7 % | -26.4 % | -5.2 % | 0.15 | 75.1 % | +32.3 % | 5 | 0.0 % | 0.0 % | 4.4 | 102.1 % | 9.7 % | 4.3 (15) |
| CNO CNO Financial Group Inc | 07/27 | +51 % | 68 6/22 | Stage 2 | C 50 | 7 of 9 | 5.1 $ | Insurance - Life | – | — | — | Financial Services | 55.10 $ | +25.2 % | +20.5 % | +52.0 % | −2.1 % | -6.1 % | 76 | 84 | 2.0 % | 1.9 % | 0.82 | 22.2 | 9.7 | 1.1 | 2.1 | 7.5 | 1.29 | 0.0 | 9.7 % | 38.9 % | 5.4 % | 9.8 % | 1.0 % | 1.72 | 6.4 % | +0.9 % | 5 | 1.3 % | 15.7 % | 0.6 | 97.4 % | 0.0 % | 3.0 (5) |
| GOLF Acushnet Holdings Corp | 08/06 | +41 % | 64 8/31 | Stage 2 | C 45 | 3 of 9 | 5.9 $ | Leisure | – | — | — | Consumer Cyclical | 101.30 $ | +36.1 % | +42.7 % | +29.1 % | 0 % | -0.9 % | 76 | 24 | 3.6 % | 3.3 % | 0.81 | 35.5 | 27.0 | 2.3 | 7.2 | 66.2 | 3.61 | 20.9 | 17.5 % | 47.5 % | 6.5 % | 21.0 % | 8.2 % | 1.40 | 31.7 % | +4.1 % | 5 | 1.0 % | 50.8 % | 7.0 | 57.5 % | 12.6 % | 3.1 (8) |
| OSW OneSpaWorld Holdings Ltd | 07/29 | +52 % | 64 8/31 | Stage 2 | B 63 | 8 of 9 | 2.6 $ | Leisure | – | — | — | Consumer Cyclical | 25.80 $ | +36.1 % | +30.6 % | +17.5 % | −6.8 % | +20.9 % | 76 | 75 | 4.7 % | 3.5 % | 0.90 | 35.6 | 27.9 | 2.6 | 4.8 | 32.5 | — | 22.7 | 9.2 % | 13.4 % | 8.0 % | 14.2 % | 8.2 % | 0.17 | 79.1 % | +7.4 % | 6 | 0.8 % | 19.1 % | 7.9 | 111.4 % | 6.3 % | 5.0 (4) |
| MCY Mercury General Corporation | 08/04 | +91 % | 55 5/22 | Stage 2 | B 60 | 8 of 9 | 5.9 $ | Insurance - Property & Casualty | Neutral | — | Financial Services | 107.10 $ | +14.0 % | +14.0 % | +56.9 % | −3.6 % | +12.0 % | 76 | 86 | 2.7 % | 2.8 % | 0.91 | 7.3 | 19.8 | 1.0 | 2.3 | 4.2 | 1.11 | 0.0 | 15.8 % | 25.2 % | 13.7 % | 38.1 % | 7.1 % | 0.23 | 26.2 % | +9.4 % | 7 | 1.2 % | 11.5 % | 2.8 | 48.2 % | 4.1 % | 5.0 (1) | |
| UVE Universal Insurance Holdings Inc | 07/23 | +60 % | 70 6/22 | Stage 2 | B 58 | 6 of 9 | 1.2 $ | Insurance - Property & Casualty | Threatened | — | — | Financial Services | 43.70 $ | +19.3 % | +22.2 % | +89.4 % | −5.9 % | +3.0 % | 76 | 71 | 3.6 % | 3.2 % | 0.73 | — | 10.0 | 0.8 | — | 3.6 | — | 0.0 | 18.6 % | 25.9 % | 13.5 % | 38.9 % | 5.7 % | — | 21.1 % | +4.9 % | 6 | 1.5 % | 8.7 % | 3.0 | 75.7 % | 5.8 % | 4.0 (1) |
| AMCX AMC Networks Inc | 08/14 | -3 % | 36 4/24 | Stage 2 | D 29 | 5 of 9 | 0.5 $ | Entertainment | Threatened | — | Communication Services | 11.20 $ | +3.2 % | +3.8 % | +87.0 % | −11.3 % | -22.6 % | 76 | 83 | 4.8 % | 4.7 % | 1.32 | — | 4.8 | 0.2 | — | 2.6 | 1.76 | 1.6 | — | 48.3 % | -0.9 % | 6.3 % | 2.7 % | — | — | -4.5 % | 4 | 0.0 % | 0.0 % | 7.1 | 106.1 % | 21.2 % | 2.5 (8) | |
| CURB Curbline Properties Corp. | 07/27 | — | 31 3/21 | Stage 2 | B 59 | 4 of 9 | 3.2 $ | REIT - Retail | – | — | — | Real Estate | 30.60 $ | +35.2 % | +36.1 % | +42.5 % | −0.7 % | +8.9 % | 75 | 9 | 2.2 % | 2.3 % | — | — | 50.5 | 15.7 | — | 26.3 | — | 26.5 | 13.1 % | 75.2 % | 13.1 % | 1.7 % | 1.0 % | — | 72.3 % | +51.3 % | 8 | 2.2 % | 130.2 % | 6.8 | 119.7 % | 29.5 % | 3.4 (9) |
| WKC World Kinect Corporation | 07/30 | +17 % | 93 4/10 | Stage 2 | D 37 | 5 of 9 | 2.0 $ | Oil & Gas Refining & Marketing | Neutral | — | — | Energy | 39.90 $ | +37.5 % | +44.2 % | +50.8 % | −0.7 % | -5.6 % | 75 | 23 | 2.9 % | 2.7 % | 1.21 | — | 14.0 | 0.0 | 1.8 | 105.1 | 1.32 | 62.3 | 0.7 % | 2.7 % | -0.4 % | -36.0 % | 2.8 % | 0.66 | 17.7 % | -12.7 % | 3 | 2.3 % | 28.8 % | 3.7 | 114.3 % | 18.9 % | 2.5 (4) |
| QUAD Quad Graphics Inc | 08/04 | +49 % | 60 7/29 | Stage 2 | C 51 | 5 of 9 | 0.5 $ | Specialty Business Services | – | — | — | Industrials | 10.40 $ | +31.4 % | +34.5 % | +105.5 % | −7.1 % | +15.4 % | 75 | 64 | 3.4 % | 3.2 % | 1.09 | — | 8.7 | 0.2 | — | 12.1 | 0.84 | 6.3 | — | 21.6 % | 1.3 % | 25.6 % | 5.5 % | — | — | -9.4 % | 4 | 3.9 % | 32.3 % | 2.0 | 56.1 % | 4.7 % | 4.5 (2) |
| RCMT RCM Technologies Inc | 08/05 | +18 % | 90 11/29 | Stage 2 | C 52 | 4 of 9 | 0.2 $ | Conglomerates | – | — | — | Industrials | 28.30 $ | +35.9 % | +37.5 % | +17.3 % | −15.5 % | +38.3 % | 75 | 30 | 4.6 % | 5.1 % | 0.29 | 13.7 | 16.2 | 0.6 | 4.5 | 56.9 | 1.36 | 8.9 | — | 27.7 % | 5.0 % | 40.6 % | 11.9 % | 0.78 | — | +14.7 % | — | 0.0 % | 0.0 % | 7.3 | 45.2 % | 4.5 % | — |
| GL Globe Life Inc | 07/22 | +23 % | 78 7/22 | Stage 2 | B 58 | 8 of 9 | 14.2 $ | Insurance - Life | Uses AI | — | Financial Services | 182.30 $ | +26.1 % | +25.5 % | +30.8 % | −2.6 % | +6.4 % | 74 | 60 | 2.2 % | 2.3 % | 0.47 | 12.8 | 11.6 | 2.3 | 2.4 | 11.5 | 1.30 | 0.0 | 23.8 % | 33.9 % | 19.6 % | 20.5 % | 3.3 % | 0.50 | 19.7 % | +3.8 % | 5 | 0.7 % | 7.9 % | 4.8 | 86.5 % | 0.1 % | 3.9 (10) | |
| IMAX Imax Corp | 07/23 | +54 % | 75 7/24 | Stage 2 | B 59 | 4 of 9 | 2.6 $ | Entertainment | – | — | — | Communication Services | 47.80 $ | +21.7 % | +7.3 % | +85.5 % | −4.8 % | +5.2 % | 74 | 82 | 3.8 % | 4.2 % | 0.37 | — | 31.1 | 6.2 | — | 20.3 | 0.89 | 20.7 | 12.2 % | 59.7 % | 9.8 % | 10.7 % | 6.7 % | — | 37.6 % | +16.5 % | 8 | 0.0 % | 0.0 % | 5.9 | 96.2 % | 18.0 % | 4.4 (11) |
| HG Hamilton Insurance Group, Ltd. | 08/05 | — | 99 12/22 | Stage 2 | B 61 | 7 of 9 | 3.6 $ | Insurance - Reinsurance | Uses AI | — | Financial Services | 36.00 $ | +29.6 % | +33.8 % | +79.1 % | 0 % | -0.4 % | 74 | 82 | 2.8 % | 2.7 % | 0.46 | 5.7 | 0.0 | 1.2 | 1.3 | 3.9 | — | 0.0 | 29.1 % | 40.5 % | 21.7 % | 33.7 % | 6.0 % | 0.05 | 29.5 % | +15.3 % | 8 | 6.6 % | 44.5 % | 0.8 | 83.6 % | 3.0 % | 3.8 (6) | |
| BGSF BG Staffing Inc | 08/05 | +5 % | 94 12/29 | Stage 2 | D 41 | 5 of 9 | 0.1 $ | Staffing & Employment Services | – | — | — | Industrials | 5.60 $ | +23.8 % | +23.2 % | +68.6 % | −32.0 % | +87.8 % | 74 | 16 | 4.2 % | 3.7 % | 0.42 | — | 16.6 | 0.6 | — | — | 0.41 | 5.5 | — | 35.6 % | -12.0 % | -16.5 % | -3.7 % | — | — | -65.8 % | — | 25.2 % | 0.0 % | 12.0 | 35.2 % | 0.5 % | — |
| FCAP First Capital Inc | 10/23 | +45 % | 41 4/22 | Stage 2 | B 70 | 7 of 9 | 0.2 $ | Banks - Regional | Neutral | — | — | Financial Services | 63.30 $ | +11.4 % | +7.8 % | +82.4 % | −11.3 % | — | 74 | 73 | 3.1 % | 3.2 % | 0.73 | 12.7 | 9.6 | 3.2 | 1.6 | 9.6 | — | 0.0 | — | 100.0 % | 33.9 % | 13.5 % | 1.4 % | — | — | +12.4 % | — | 1.9 % | 23.8 % | 0.1 | 26.7 % | 1.8 % | — |
| LWAY Lifeway Foods Inc | 08/11 | +103 % | 47 3/16 | Stage 3 | B 67 | 5 of 9 | 0.5 $ | Packaged Foods | – | — | — | Consumer Defensive | 29.80 $ | +18.1 % | +24.7 % | +18.1 % | −11.3 % | +15.8 % | 74 | 71 | 5.5 % | 4.7 % | 0.45 | — | 29.9 | 2.0 | — | — | 3.50 | 18.1 | — | 29.7 % | 6.5 % | 18.2 % | 12.2 % | — | — | +13.7 % | — | 0.0 % | 0.0 % | 11.3 | 43.0 % | 5.4 % | 5.0 (1) |
| PBF PBF Energy Inc | 07/30 | +4 % | 93 4/10 | Stage 2 | B 58 | 5 of 9 | 8.5 $ | Oil & Gas Refining & Marketing | – | — | — | Energy | 72.30 $ | +52.2 % | +77.7 % | +230.9 % | −19.0 % | -16.3 % | 73 | 9 | 6.0 % | 5.8 % | 0.10 | — | 12.0 | 0.2 | — | 11.5 | 2.51 | 3.8 | -1.3 % | 6.2 % | 3.9 % | 8.2 % | -2.0 % | — | 37.5 % | -11.4 % | 3 | 1.5 % | 20.7 % | 5.4 | 85.7 % | 14.0 % | 2.7 (15) |
| ESCA Escalade Incorporated | 08/07 | +18 % | 86 11/31 | Stage 2 | C 54 | 7 of 9 | 0.3 $ | Leisure | – | — | — | Consumer Cyclical | 19.90 $ | +42.3 % | +45.8 % | +68.2 % | −13.6 % | +30.3 % | 73 | 81 | 4.5 % | 3.8 % | 0.60 | 18.7 | 15.8 | 1.1 | 1.6 | 10.7 | 1.05 | 10.3 | — | 27.9 % | 6.4 % | 9.0 % | 5.8 % | 0.10 | — | -4.5 % | — | 3.2 % | 54.0 % | 12.6 | 31.7 % | 2.0 % | — |
| PFIS Peoples Financial Services Corp. | 07/30 | +24 % | 69 6/22 | Stage 2 | B 56 | 4 of 9 | 0.7 $ | Banks - Regional | – | — | — | Financial Services | 70.40 $ | +34.8 % | +35.6 % | +51.2 % | −0.6 % | -10.5 % | 72 | 31 | 3.1 % | 3.0 % | 0.74 | 12.4 | 15.1 | 2.4 | 1.4 | 16.8 | 1.31 | 0.0 | — | 100.0 % | 29.8 % | 11.7 % | 1.1 % | 0.60 | — | +22.3 % | 5 | 3.5 % | 43.0 % | 3.5 | 32.3 % | 2.3 % | 4.0 (2) |
| RYTM Rhythm Pharmaceuticals Inc | 08/04 | +170 % | 39 4/22 | Stage 3 | B 57 | 5 of 9 | 6.7 $ | Biotechnology | – | — | — | Healthcare | 99.30 $ | -0.8 % | -2.0 % | +16.5 % | −11.4 % | +39.8 % | 70 | 42 | 5.8 % | 4.8 % | 1.88 | — | 0.0 | 31.0 | 55.4 | — | — | -12.6 | -87.1 % | 89.4 % | -93.3 % | -101.2 % | -29.8 % | 1.85 | 27.8 % | +45.8 % | 5 | 0.0 % | 0.0 % | -4.6 | 110.0 % | 14.1 % | 4.7 (12) |
| PAYO Payoneer Global Inc | 08/05 | +17 % | 73 7/25 | Stage 3 | B 60 | 4 of 9 | 2.4 $ | Software - Infrastructure | – | — | — | Technology | 7.20 $ | +25.6 % | +25.3 % | +9.1 % | −8.2 % | +2.8 % | 70 | 61 | 1.2 % | 4.3 % | 0.95 | 36.2 | 0.0 | 2.3 | 3.7 | 12.3 | — | 11.1 | 11.5 % | 84.9 % | 6.8 % | 10.2 % | 1.1 % | 0.12 | 7.7 % | +7.7 % | 6 | 0.0 % | 0.0 % | 3.5 | 91.9 % | 5.4 % | 4.4 (9) |
| ETR Entergy Corporation | 07/29 | +53 % | 32 2/15 | Stage 2 | B 60 | 5 of 9 | 48.6 $ | Utilities - Regulated Electric | – | — | — | Utilities | 107.60 $ | +24.6 % | +27.0 % | +22.1 % | −2.6 % | +15.4 % | 69 | 52 | 1.7 % | 2.0 % | 0.49 | 27.6 | 24.8 | 3.7 | 2.9 | — | 2.00 | 12.7 | 18.7 % | 47.0 % | 13.3 % | 10.8 % | 2.7 % | 2.01 | 22.9 % | +9.0 % | 1 | 2.4 % | 64.1 % | 4.4 | 97.9 % | 5.6 % | 4.0 (20) |
| DTM DT Midstream Inc | 07/30 | +84 % | 98 5/10 | Stage 2 | B 58 | 8 of 9 | 13.9 $ | Oil & Gas Midstream | – | — | — | Energy | 138.00 $ | +24.4 % | +24.2 % | +38.0 % | −2.1 % | +12.3 % | 69 | 65 | 2.3 % | 2.2 % | 0.74 | 30.0 | 26.0 | 10.6 | 2.9 | 26.5 | — | 15.8 | 49.7 % | 75.3 % | 35.7 % | 9.9 % | 4.0 % | 0.85 | 46.8 % | +26.7 % | 5 | 2.6 % | 74.4 % | 5.1 | 88.5 % | 5.3 % | 3.7 (15) |
| WRLD World Acceptance Corporation | 07/23 | +15 % | 80 7/22 | Stage 2 | C 49 | 7 of 9 | 0.8 $ | Credit Services | Neutral | — | Financial Services | 179.80 $ | +31.5 % | +51.3 % | +14.3 % | −0.4 % | +16.8 % | 68 | 29 | 5.1 % | 4.4 % | 1.14 | 26.1 | 9.6 | 1.4 | 2.4 | 3.2 | 0.70 | 0.0 | — | 69.2 % | 6.6 % | 8.8 % | 6.3 % | 1.88 | — | +3.7 % | 4 | 0.0 % | 0.0 % | 9.7 | 95.5 % | 311.5 % | 3.0 (2) | |
| FLNG FLEX LNG Ltd | 08/19 | +15 % | 98 5/10 | Stage 2 | D 34 | 5 of 9 | 1.7 $ | Oil & Gas Midstream | – | — | — | Energy | 31.20 $ | +30.5 % | +26.8 % | +38.9 % | −10.3 % | -17.1 % | 67 | 54 | 2.5 % | 2.4 % | 0.18 | — | 13.2 | 4.9 | — | 16.1 | — | 12.8 | — | 73.0 % | 22.3 % | 10.2 % | 3.9 % | — | — | -2.4 % | 4 | 9.6 % | 2.6 % | 4.6 | 28.5 % | 13.9 % | 3.0 (2) |
| FTDR Frontdoor Inc | 08/04 | +46 % | 86 11/31 | Stage 2 | B 64 | 8 of 9 | 5.1 $ | Personal Services | – | — | — | Consumer Cyclical | 72.60 $ | +26.9 % | +31.4 % | +24.2 % | −1.1 % | +4.3 % | 66 | 63 | 3.0 % | 3.1 % | 1.46 | 20.9 | 16.6 | 2.4 | 22.2 | 13.2 | 2.38 | 11.2 | 14.6 % | 55.2 % | 12.2 % | 121.0 % | 12.0 % | -1.62 | 10.6 % | +13.6 % | 5 | 0.0 % | 0.0 % | 6.6 | 107.0 % | 6.2 % | 3.8 (6) |
| BNL Broadstone Net Lease Inc | 07/29 | +24 % | 74 6/21 | Stage 2 | B 62 | 6 of 9 | 4.3 $ | REIT - Diversified | – | — | — | Real Estate | 21.40 $ | +23.1 % | +25.0 % | +40.4 % | −2.2 % | +9.3 % | 66 | 89 | 2.0 % | 1.8 % | 0.97 | 33.5 | 29.1 | 8.9 | 1.4 | 16.6 | — | 15.9 | 52.2 % | 94.9 % | 30.6 % | 4.2 % | 2.7 % | 0.93 | 49.5 % | +4.6 % | 4 | 5.5 % | 101.7 % | 3.9 | 95.7 % | 8.7 % | 3.6 (11) |
Price Chart
Quarterly Figures
No quarterly data available.
Frequently Asked Questions
Weekly Closing Range ≥ 90 and Daily Closing Range ≥ 70 — a very tight, strong weekly range closing near the high.
All scanners are recalculated daily across the entire stock universe — most recently on 3. August 2026. The data basis is fundamental data and SEC filings (10-K annual reports and 10-Q quarterly reports).
Currently, 223 stocks pass this scanner's criteria (as of 3. August 2026). The 100 strongest hits are shown.
Global filters: market cap of $50B or less (mega caps are cut from every scanner); 10- and 30-day ADR must be ≥ 1% (too little movement gets cut); names after a reverse split (distorted price history) and names with a red Stress RS (rating ≤ 30 — weak on stress days) are excluded.
Related scanners
- ATH
- Ants
- Ben Bennett: Power of Four
- Bullish Reversal Bar
- Gap-Up (≥3%)
- Green Line Breakout
- High ADR — Hot Theme
- Inside Day
- Inside Day at Highs
- Mark Minervini: Power Play
- Oliver Kell: Bull Snorts
- Oliver Kell: Gappers
- Oops Reversal
- Pocket Pivot
- Pradeep Bonde: $ Breakout Bullish
- Pradeep Bonde: 4% Breakout Bullish
- Qullamaggie: Continuation Base
- Qullamaggie: Episodic Pivot
- Qullamaggie: High Tight Flag
- Strong DCR (≥80)
- Tight & Near High
- Tight Weekly Closes
- Volume Surge
- Volume Surge
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.